Get the Stockscreener App
3.30
0.61%
0.02
After Hours:
3.30
Theratechnologies Inc stock is traded at $3.30, with a volume of 696.40K.
It is up +0.61% in the last 24 hours and up +2.80% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$3.28
Open:
$3.27
24h Volume:
696.40K
Relative Volume:
1.31
Market Cap:
$151.73M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-66.00
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
+0.92%
1M Performance:
+2.80%
6M Performance:
+114.29%
1Y Performance:
+166.13%
1-Day Range:
$3.26
$3.31
1-Week Range:
$3.26
$3.31
52-Week Range:
$1.12
$3.31
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
3.30 | 150.35M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
Theratechnologies shareholders approve acquisition by Future Pak affiliate - Investing.com India
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 31.4% in August - MarketBeat
Theratechnologies shareholders approve acquisition by Future Pak affiliate By Investing.com - Investing.com South Africa
Theratechnologies Shareholders Approve Acquisition by Future Pak Affiliate - TipRanks
Theratechnologies (THTX) Shareholders Approve Key Arrangement with CB Biotechnology - GuruFocus
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewswire
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - Benzinga
97.4% Shareholder Approval: Theratechnologies Set for Future Pak Acquisition in Biotech Deal - Stock Titan
Does Theratechnologies Inc. have a sustainable dividendJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Lancaster City Council
Is This a Bottoming Phase for Theratechnologies Inc.2025 Trading Recap & Free High Return Stock Watch Alerts - beatles.ru
Theratechnologies Launches EGRIFTA WR™ for HIV-Related Lipodystrophy - MSN
How hedge fund analytics apply to Theratechnologies Inc. stockJuly 2025 WrapUp & Long-Term Safe Return Strategies - Newser
Theratechnologies Gains Support for Future Pak Acquisition - MSN
What’s the outlook for Theratechnologies Inc.’s sectorJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - خودرو بانک
Nantahala Capital Management LLC Decreases Holdings in Theratechnologies Inc. $THTX - MarketBeat
Will Theratechnologies Inc. outperform the market2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Theratechnologies Inc. stock chart pattern explainedJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
Theratechnologies Announces Availability of EGRIFTA WR™ - GlobeNewswire
Aug PostEarnings: Will Theratechnologies Inc. benefit from geopolitical trendsJobs Report & Weekly High Return Opportunities - خودرو بانک
Theratechnologies Inc. - Baystreet.ca
Stocks In Play: Theratechnologies Inc. - Barchart.com
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval - MarketScreener
Will Theratechnologies Inc. bounce back from current supportJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - Newser
Theratechnologies (THTX) Launches New EGRIFTA WR Formulation for HIV Patients - GuruFocus
Applying Elliott Wave Theory to Theratechnologies Inc.Recession Risk & Safe Entry Point Identification - Newser
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy - The Manila Times
Weekly HIV Treatment Breakthrough: Theratechnologies' EGRIFTA WR Cuts Injection Volume by 50% - Stock Titan
Advanced analytics toolkit walkthrough for Theratechnologies Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Theratechnologies Inc. recovery potential after sell off2025 Key Lessons & Weekly Top Stock Performers List - Newser
Will Theratechnologies Inc. see short term momentumQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Theratechnologies Inc. stock daily chart insights2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
What the charts say about Theratechnologies Inc. today2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Will Theratechnologies Inc. outperform small cap indexesJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Analyzing recovery setups for Theratechnologies Inc. investors2025 Earnings Impact & Reliable Trade Execution Plans - Newser
Is Theratechnologies Inc. exposed to currency risks2025 Biggest Moves & Community Shared Stock Ideas - خودرو بانک
What are Theratechnologies Inc.’s growth levers2025 Pullback Review & Fast Entry Momentum Trade Alerts - خودرو بانک
Real time social sentiment graph for Theratechnologies Inc.2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Will Theratechnologies Inc. rebound enough to break even2025 Key Highlights & High Conviction Investment Ideas - Newser
Published on: 2025-09-03 23:17:32 - Newser
Regression analysis insights on Theratechnologies Inc. performance2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Statistical indicators supporting Theratechnologies Inc.’s strengthJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Will Theratechnologies Inc. benefit from geopolitical trendsJuly 2025 Recap & Low Risk High Win Rate Picks - خودرو بانک
Can Theratechnologies Inc. sustain its profitabilityJuly 2025 Final Week & Growth Focused Stock Pick Reports - خودرو بانک
Using RSI to spot recovery in Theratechnologies Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
What earnings revisions data tells us about Theratechnologies Inc.Quarterly Trade Review & Safe Entry Point Identification - Newser
Signal strength of Theratechnologies Inc. stock in tech scannersWeekly Volume Report & Free Community Consensus Stock Picks - Newser
Real Time Data Flags Unusual Activity in Theratechnologies Inc.GDP Growth & Risk Managed Investment Strategies - beatles.ru
Using R and stats models for Theratechnologies Inc. forecastingWeekly Profit Analysis & Reliable Volume Spike Trade Alerts - Newser
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):